Clinical Trial Update: Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chemotherapy with filgrastim and radiation therapy for primary central nervous system lymphoma has been withdrawn. The study was spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Filgrastim (Neupogen) (filgrastim)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: WITHDRAWN